If on one side the glycation might prevent the ACE2-Spike interaction in diabetes mellitus, as previously suggested (13), on the other side the mutations of the Omicron-variant Spike protein, leading to the loss of a lysine glycation site, may be responsible for a relatively augmented binding affinity to ACE2 (compare with Figure 3). This evidence concerns the gene ACE2 and diabetes mellitus.